$MNKD
MANNKIND CORP

2015 Q1 Form 10-K Financial Statement

#000119312515073647 Filed on March 02, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $1.900M
YoY Change
Gross Profit -$1.900M
YoY Change
Gross Profit Margin
Selling, General & Admin $10.50M $12.50M $79.38M
YoY Change -30.92% -28.98% 32.97%
% of Gross Profit
Research & Development $9.377M $17.60M $100.2M
YoY Change -64.19% -39.31% -8.64%
% of Gross Profit
Depreciation & Amortization $2.300M $3.010M $9.800M
YoY Change -8.0% -23.8% -14.78%
% of Gross Profit
Operating Expenses $21.74M $30.10M $179.6M
YoY Change -47.51% -35.41% 6.04%
Operating Profit -$21.74M -$179.6M
YoY Change -47.51% 6.04%
Interest Expense -$10.30M -$6.400M $20.40M
YoY Change 114.58% 1.59% -5.12%
% of Operating Profit
Other Income/Expense, Net $1.413M $0.00 -$18.76M
YoY Change -123.99% -100.0% 2853.54%
Pretax Income -$30.66M -$36.40M -$198.4M
YoY Change -41.11% -32.09% 3.6%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$30.66M -$36.44M -$198.4M
YoY Change -41.11% -31.99% 3.6%
Net Earnings / Revenue
Basic Earnings Per Share -$2.57
Diluted Earnings Per Share -$383.3K -$458.4K -$2.57
COMMON SHARES
Basic Shares Outstanding 408.8M shares 405.7M shares 77.05M shares
Diluted Shares Outstanding 77.05M shares

Balance Sheet

Concept 2015 Q1 2014 Q4 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.8M $120.8M $120.8M
YoY Change 237.43% 70.62% 70.62%
Cash & Equivalents $120.8M $120.8M $120.8M
Short-Term Investments
Other Short-Term Assets $16.40M $20.20M $20.20M
YoY Change 355.56% 267.27% 267.27%
Inventory $16.79M $9.670M $9.700M
Prepaid Expenses $15.00M
Receivables $4.282M $50.44M $50.40M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $158.3M $201.2M $201.2M
YoY Change 301.76% 163.72% 163.7%
LONG-TERM ASSETS
Property, Plant & Equipment $193.5M $192.1M $192.1M
YoY Change 9.71% 8.82% 8.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.027M $848.0K $1.200M
YoY Change -75.97% -84.63% -79.31%
Total Long-Term Assets $201.7M $193.3M $193.2M
YoY Change 8.95% 5.99% 5.98%
TOTAL ASSETS
Total Short-Term Assets $158.3M $201.2M $201.2M
Total Long-Term Assets $201.7M $193.3M $193.2M
Total Assets $360.0M $394.4M $394.4M
YoY Change 60.33% 52.5% 52.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.302M $7.394M $7.400M
YoY Change -9.24% 91.55% 89.74%
Accrued Expenses $12.38M $26.21M $17.30M
YoY Change -17.49% 21.13% 10.9%
Deferred Revenue
YoY Change
Short-Term Debt $73.40M $73.00M $73.00M
YoY Change 183.4% -28.64% -28.64%
Long-Term Debt Due $99.60M $99.40M $99.40M
YoY Change
Total Short-Term Liabilities $380.8M $403.4M $403.4M
YoY Change 755.34% 215.63% 215.65%
LONG-TERM LIABILITIES
Long-Term Debt $49.50M $52.60M $52.60M
YoY Change -66.6% -64.46% -64.46%
Other Long-Term Liabilities $26.78M $12.30M $12.30M
YoY Change 87.02% -9.58% -9.56%
Total Long-Term Liabilities $26.78M $12.30M $64.90M
YoY Change 87.02% -9.58% -59.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $380.8M $403.4M $403.4M
Total Long-Term Liabilities $26.78M $12.30M $64.90M
Total Liabilities $457.1M $468.2M $468.2M
YoY Change 120.78% 61.81% 61.78%
SHAREHOLDERS EQUITY
Retained Earnings -$2.525B -$2.495B
YoY Change 8.64%
Common Stock $2.428B $2.421B
YoY Change 2.64% 6.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$97.03M -$73.77M -$73.80M
YoY Change
Total Liabilities & Shareholders Equity $360.0M $394.4M $394.4M
YoY Change 60.33% 52.5% 52.51%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014
OPERATING ACTIVITIES
Net Income -$30.66M -$36.44M -$198.4M
YoY Change -41.11% -31.99% 3.6%
Depreciation, Depletion And Amortization $2.300M $3.010M $9.800M
YoY Change -8.0% -23.8% -14.78%
Cash From Operating Activities $3.020M -$35.74M $4.090M
YoY Change -108.16% 4.96% -103.18%
INVESTING ACTIVITIES
Capital Expenditures $4.203M -$4.970M $24.10M
YoY Change 198.3% -19.45% 201.7%
Acquisitions
YoY Change
Other Investing Activities -$9.250M $0.00
YoY Change
Cash From Investing Activities -$4.200M -$14.22M -$24.10M
YoY Change 197.87% 130.47% 201.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.190M -1.670M 70.06M
YoY Change -64.69% -109.71% -51.9%
NET CHANGE
Cash From Operating Activities 3.020M -35.74M 4.090M
Cash From Investing Activities -4.200M -14.22M -24.10M
Cash From Financing Activities 1.190M -1.670M 70.06M
Net Change In Cash 10.00K -51.63M 50.05M
YoY Change -100.03% 124.28% 459.22%
FREE CASH FLOW
Cash From Operating Activities $3.020M -$35.74M $4.090M
Capital Expenditures $4.203M -$4.970M $24.10M
Free Cash Flow -$1.183M -$30.77M -$20.01M
YoY Change -96.92% 10.37% -85.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 mnkd Shares Reserved For Employee Stock Purchase Plan
SharesReservedForEmployeeStockPurchasePlan
700000 shares
CY2012Q4 mnkd Increase Decrease In Fair Value Recognized In Other Income
IncreaseDecreaseInFairValueRecognizedInOtherIncome
12000000
CY2012Q4 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2012Q1 mnkd Units Sold Warrant Portion Convertible Into Common Stock
UnitsSoldWarrantPortionConvertibleIntoCommonStock
0.6
CY2012Q1 mnkd Units Sold Under Public Offer Underwritten
UnitsSoldUnderPublicOfferUnderwritten
35937500 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2012Q2 mnkd Fair Value Of Units Issued
FairValueOfUnitsIssued
1.69
CY2012Q2 mnkd Fair Value Input Discount For Lack Of Marketability
FairValueInputDiscountForLackOfMarketability
0.0042 pure
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
408837603 shares
CY2012Q2 mnkd Restricted Stock Agreed To Be Purchased By Lender
RestrictedStockAgreedToBePurchasedByLender
77200000
CY2004Q3 mnkd Operating Loss Carryforwards Subject To Limitation
OperatingLossCarryforwardsSubjectToLimitation
216000000
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.60
CY2014Q2 dei Entity Public Float
EntityPublicFloat
2616079653
CY2014Q2 mnkd Number Of Employees
NumberOfEmployees
124 Employee
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-313652000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2681000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2012Q4 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-110679000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61840000
CY2012Q4 mnkd Fair Value Of Units Issued
FairValueOfUnitsIssued
2.40
CY2012Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
289000
CY2012Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
369391972 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
369391972 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.90
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.35
CY2013Q4 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
9115821 shares
CY2013Q4 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5485000
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2082000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
3697000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3860000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2296402000
CY2013Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
102300000
CY2013Q4 mnkd Loan Commitment Asset
LoanCommitmentAsset
5200000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24237940 shares
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
817000000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
111060000
CY2013Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
98439000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2261996000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21634000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-30713000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13605000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5706000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
127794000
CY2013Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
49521000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
258646000
CY2013Q4 us-gaap Liabilities
Liabilities
289359000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12193000
CY2013Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
342000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70790000
CY2013Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
67700000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
176557000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
40972000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
817000000
CY2013Q4 mnkd Shares Reserved For Employee Stock Purchase Plan
SharesReservedForEmployeeStockPurchasePlan
700000 shares
CY2013Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5516000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
76275000
CY2013Q4 mnkd Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
7811000
CY2013Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
282000
CY2013Q4 mnkd Accrued Interest Of Related Party Debt
AccruedInterestOfRelatedPartyDebt
600000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2539000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
70091000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
41219000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
837000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
287617000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
653896000
CY2013Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
298000
CY2013Q4 us-gaap Assets
Assets
258646000
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
3578000
CY2013Q4 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
30100000
CY2013Q4 mnkd Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
30421000
CY2013Q4 mnkd Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
6608000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
406059089 shares
CY2013Q4 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
1311000
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
406059089 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.20
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
21307827 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.53
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
18439472 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.42
CY2014Q4 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.52
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
4 Derivative
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2610720 shares
CY2014Q4 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
15506488 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21541664 shares
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
882502000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118221000
CY2014Q4 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
23300000
CY2014Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
23300000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20000000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
403353000
CY2014Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
23300000
CY2014Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
49521000
CY2014Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2396000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
4061000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7394000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2494784000
CY2014Q4 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
23300000
CY2014Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
72995000
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
35000000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2416967000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26206000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-73770000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15335000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7539000
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
20000000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
394439000
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
197403000
CY2014Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
99355000
CY2014Q4 us-gaap Line Of Credit
LineOfCredit
80000000
CY2014Q4 us-gaap Liabilities
Liabilities
468209000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14928000
CY2014Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
1343000
CY2014Q4 us-gaap Purchase Obligation
PurchaseObligation
120100000
CY2014Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
23200000
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5000000
CY2014Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
30100000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120841000
CY2014Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
118500000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
192127000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33495000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
882502000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20206000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
33253000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3010000
CY2014Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
19217000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1800000000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
73227000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
43691000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
131000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
95000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
310348000
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
30356000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
699997000
CY2014Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
311000
CY2014Q4 us-gaap Assets
Assets
394439000
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
768000
CY2014Q4 us-gaap Inventory Net
InventoryNet
9670000
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4856000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50436000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
848000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
201153000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1400000000
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4719000
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15000000
CY2014Q4 mnkd Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
8624000
CY2014Q4 mnkd Weighted Average Grant Date Fair Value Of Restricted Stock Units Expected To Vest
WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest
5.23
CY2014Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
816000
CY2014Q4 mnkd Share Based Compensation Arrangement Restricted Stock Units Number Of Units Expected To Vest
ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest
2386061 shares
CY2014Q4 mnkd Accrued Interest Of Related Party Debt
AccruedInterestOfRelatedPartyDebt
3500000
CY2014Q4 mnkd Shares Reserved For Employee Stock Purchase Plan
SharesReservedForEmployeeStockPurchasePlan
700000 shares
CY2014Q4 mnkd Derivative Fair Value Liability Shares Issuable To Lender
DerivativeFairValueLiabilitySharesIssuableToLender
16500000 shares
CY2014Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2014Q4 mnkd Potential Proceeds From Warrant Exercises
PotentialProceedsFromWarrantExercises
19500000
CY2014Q4 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
30100000
CY2014Q4 mnkd Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
28516000
CY2014Q4 mnkd Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
5321000
CY2012Q1 mnkd Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
80600000
CY2012Q2 us-gaap Forward Contract Indexed To Issuers Equity Shares
ForwardContractIndexedToIssuersEquityShares
250000000 shares
CY2014Q3 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
7900000
CY2014Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1400000
CY2014Q3 mnkd Total Consideration Received
TotalConsiderationReceived
9300000
CY2012Q4 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.023 pure
CY2012Q4 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0011 pure
CY2012Q4 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.015 pure
CY2012Q4 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0000 pure
CY2004Q1 mnkd Percentage Of Common Stock Shares Outstanding
PercentageOfCommonStockSharesOutstanding
0.01 pure
CY2004Q3 mnkd Net Operating Loss Carryforward Annual Limitation
NetOperatingLossCarryforwardAnnualLimitation
13000000
CY2012Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
40000000 shares
CY2012Q4 mnkd Additional Purchase Of Common Stock
AdditionalPurchaseOfCommonStock
4500000 shares
CY2012Q4 mnkd Additional Commons Stock Shares Issued During Period
AdditionalCommonsStockSharesIssuedDuringPeriod
6000000 shares
CY2012Q4 mnkd Warrant Expiration Month Year
WarrantExpirationMonthYear
2013-10
CY2012Q4 mnkd Common Stock Purchase
CommonStockPurchase
30000000 shares
CY2012Q4 mnkd Common Stock Issuable Upon Exercise Of Warrants Conversion Ratio
CommonStockIssuableUponExerciseOfWarrantsConversionRatio
0.75 pure
CY2012Q4 mnkd Net Proceeds From Public Offering
NetProceedsFromPublicOffering
86300000
CY2013Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
89700000
CY2012Q4 us-gaap Forward Contract Indexed To Issuers Equity Shares
ForwardContractIndexedToIssuersEquityShares
350000000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7583 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.26
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-128732000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2013 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.65 pure
CY2013 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
463290 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
299591000 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.307 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.043 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0094 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y22D
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8626 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0182 pure
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
78475367 shares
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
48888000
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4801000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
66800000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
965000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-191490000
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1263000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2270000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-169401000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-191488000
CY2013 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
6500000
CY2013 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
598000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-635000
CY2013 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
2000
CY2013 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
115000000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7987000
CY2013 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-191490000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000
CY2013 us-gaap Interest Paid
InterestPaid
13452000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45186000
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4801000
CY2013 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
7886000
CY2013 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
856000
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
998000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45186000
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11500000
CY2013 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
400000
CY2013 us-gaap Interest Expense
InterestExpense
21500000
CY2013 us-gaap Operating Expenses
OperatingExpenses
169401000
CY2013 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
119500000
CY2013 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6309000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
14900000
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
591000
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2013 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-66849000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14057000
CY2013 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
2300000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
145669000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7987000
CY2013 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
109719000
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2013 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
533000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59682000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1071000
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
94147000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
45186000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
13900000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3100000
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
59379000
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
900000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
7470000
CY2013 us-gaap Interest Expense Debt
InterestExpenseDebt
15153000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8950000
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2013 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3675000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
645000
CY2013 mnkd Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
172149000
CY2013 mnkd Income Tax Expense Benefit Net
IncomeTaxExpenseBenefitNet
0
CY2013 mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
78000000
CY2013 mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
466000
CY2013 mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-817000
CY2013 mnkd Stock Issued During Period Value For Debt Exchange
StockIssuedDuringPeriodValueForDebtExchange
5501000
CY2013 mnkd Payments For Use Of Aircrafts
PaymentsForUseOfAircrafts
82000
CY2013 mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
52421000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
476521 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7398 pure
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.37
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Entity Registrant Name
EntityRegistrantName
MANNKIND CORP
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2014 dei Trading Symbol
TradingSymbol
MNKD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
355704 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.76
CY2014 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4086000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.14
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
6982707 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
417223 shares
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2014 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.55 pure
CY2014 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2019-12-09
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1326800 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
954127 shares
CY2014 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
305076 shares
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Financial Statement Estimates</i> &#x2014; The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. The more significant estimates reflected in these accompanying financial statements involve assessing long-lived assets for impairment, accrued expenses, including clinical study expenses, valuation of forward purchase contracts, valuation of the facility financing obligation, commitment asset, milestone rights, valuation of stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities and any valuation allowance recorded against net deferred tax assets.</font></p> </div>
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
385229000 shares
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.318 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.041 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
3.83
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0164 pure
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12.48
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.54
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.30
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M29D
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.21
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0000899460
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2014 us-gaap Line Of Credit Facility Date Of First Required Payment1
LineOfCreditFacilityDateOfFirstRequiredPayment1
2016-07-01
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8485 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0211 pure
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51463340 shares
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Concentration of Credit Risk</i> &#x2014; Financial instruments which potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents consist of interest-bearing accounts, which are regularly monitored by management and held in high credit quality institutions.</font></p> </div>
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-198392000
CY2014 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
93500000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1679000
CY2014 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-10000
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3250149 shares
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-26908000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
65500000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2014 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
22962000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14721000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
615000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9670000
CY2014 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
50436000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-198382000
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1363000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10978000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-179627000
CY2014 us-gaap Loans Assumed1
LoansAssumed1
3034000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24097000
CY2014 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
10000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-198382000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
9000
CY2014 us-gaap Interest Paid
InterestPaid
11218000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25660000
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
26908000
CY2014 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1768000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
48622000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9800000
CY2014 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
800000
CY2014 us-gaap Interest Expense
InterestExpense
20400000
CY2014 us-gaap Operating Expenses
OperatingExpenses
179627000
CY2014 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
40000000
CY2014 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
2894000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
36400000
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
900000
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
7631000
CY2014 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
200436000
CY2014 us-gaap Interest Expense Debt
InterestExpenseDebt
17549000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
50051000
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2014 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2276000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
737000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2014 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-65504000
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18575000
CY2014 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
11000000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
70062000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-24097000
CY2014 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
100244000
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2014 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
623000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
79383000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3622000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
48622000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
62700000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14900000
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
57873000
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2915000
CY2014 mnkd Increase Decrease In Stock Based Compensation Expense
IncreaseDecreaseInStockBasedCompensationExpense
23000000
CY2014 mnkd Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
27779000
CY2014 mnkd Maturity Period Of Cash Equivalents
MaturityPeriodOfCashEquivalents
90 days or less at the time of purchase
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
180855000 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.310 pure
CY2014 mnkd Long Term Purchase Commitment Expiration Date
LongTermPurchaseCommitmentExpirationDate
2019-12-31
CY2014 mnkd Amortization Period Of Lease Hold Improvements
AmortizationPeriodOfLeaseHoldImprovements
P4Y
CY2014 mnkd Income Tax Expense Benefit Net
IncomeTaxExpenseBenefitNet
0
CY2014 mnkd Deferred Tax Asset Increase Decrease In Equity
DeferredTaxAssetIncreaseDecreaseInEquity
18300000
CY2014 mnkd Value Of Restricted Stock Units Vested
ValueOfRestrictedStockUnitsVested
12500000
CY2014 mnkd Longterm Purchase Commitment Renewal Time Period
LongtermPurchaseCommitmentRenewalTimePeriod
P2Y
CY2014 mnkd Stock Options Granted Vesting Rate
StockOptionsGrantedVestingRate
0.25 pure
CY2014 mnkd Percentage Of Credit Exchange Receivable
PercentageOfCreditExchangeReceivable
0.65 pure
CY2014 mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-13000
CY2014 mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-97000
CY2014 mnkd Stock Issued During Period Value For Debt Exchange
StockIssuedDuringPeriodValueForDebtExchange
93501000
CY2014 mnkd Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
0.009 pure
CY2014 mnkd Milestone Payments
MilestonePayments
-3150000
CY2014 mnkd Payments For Use Of Aircrafts
PaymentsForUseOfAircrafts
79000
CY2014 mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
40120000
CY2014 mnkd Write Off Of Derivative Liability
WriteOffOfDerivativeLiability
363000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7000 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.99
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-119860000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2012 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
422260 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.040 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0032 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y26D
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8400 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0116 pure
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
128324123 shares
CY2012 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1237000
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-906000
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
60700000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-50000
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2012 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-117000
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
35000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1545000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-169774000
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
862000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
CY2012 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-48000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-146960000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-169416000
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1191000
CY2012 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2000
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
184537000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
637000
CY2012 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-169366000
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
CY2012 us-gaap Interest Paid
InterestPaid
9755000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13292000
CY2012 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
906000
CY2012 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
14219000
CY2012 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
4072000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13292000
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13000000
CY2012 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000
CY2012 us-gaap Interest Expense
InterestExpense
21600000
CY2012 us-gaap Operating Expenses
OperatingExpenses
146995000
CY2012 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10491000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
3000000
CY2012 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
800000
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
9199000
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
11139000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-408000
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2012 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-60739000
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14402000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
59159000
CY2012 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2012 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
15075000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
675000
CY2012 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
9200
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
179579000
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
77000
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-560000
CY2012 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
12750000
CY2012 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
101522000
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2012 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
571000
CY2012 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
6056000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45473000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
44000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
13292000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
2900000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
51540000
CY2012 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
48000
CY2012 mnkd Adjustments To Additional Paid In Capital Net Share Settlement Of Equity Awards
AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards
6056000
CY2012 mnkd Change In Fair Value Of Forward Exchange Rate Contracts
ChangeInFairValueOfForwardExchangeRateContracts
-1237000
CY2012 mnkd Income Tax Expense Benefit Net
IncomeTaxExpenseBenefitNet
0
CY2012 mnkd Forward Purchase Contract Contribution To Additional Paid In Capital
ForwardPurchaseContractContributionToAdditionalPaidInCapital
29317000
CY2012 mnkd Stock Issued During Period Value Issued Related To Legal Settlement
StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement
438000
CY2012 mnkd Nominal Lending Fee
NominalLendingFee
0.01
CY2012 mnkd Reclassification Of Forward Purchase Contract To Additional Paid In Capital
ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital
28080000
CY2012 mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
184537000
CY2012 mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-290000
CY2012 mnkd Stock Issued During Period Value Initial Public Offering
StockIssuedDuringPeriodValueInitialPublicOffering
166864000
CY2012 mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-682000
CY2012 mnkd Payments For Use Of Aircrafts
PaymentsForUseOfAircrafts
200000
CY2012 mnkd Common Shares Issued Pursuant To Litigation Settlement
CommonSharesIssuedPursuantToLitigationSettlement
438000
CY2012 mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
167735000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-40965000
CY2013Q1 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
280058000 shares
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-52056000
CY2014Q1 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
368784000 shares
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-46124000
CY2013Q2 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
284044000 shares
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-73365000
CY2014Q2 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
380770000 shares
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-50818000
CY2013Q3 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
296386000 shares
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-36520000
CY2014Q3 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
394163000 shares
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-53582000
CY2013Q4 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
337284000 shares
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-36439000
CY2014Q4 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
396793000 shares

Files In Submission

Name View Source Status
0001193125-15-073647-index-headers.html Edgar Link pending
0001193125-15-073647-index.html Edgar Link pending
0001193125-15-073647.txt Edgar Link pending
0001193125-15-073647-xbrl.zip Edgar Link pending
d844485d10k.htm Edgar Link pending
d844485dex231.htm Edgar Link pending
d844485dex311.htm Edgar Link pending
d844485dex312.htm Edgar Link pending
d844485dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g844485g43t61.jpg Edgar Link pending
mnkd-20141231.xml Edgar Link completed
mnkd-20141231.xsd Edgar Link pending
mnkd-20141231_cal.xml Edgar Link unprocessable
mnkd-20141231_def.xml Edgar Link unprocessable
mnkd-20141231_lab.xml Edgar Link unprocessable
mnkd-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending